Literature DB >> 26045980

Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma.

Xu You Liu1, Shao Hui Tang1, Sheng Lan Wu1, Yu Hong Luo2, Ming Rong Cao2, Hong Ke Zhou1, Xiang Wu Jiang1, Jian Chang Shu3, Cai Qun Bie4, Si Min Huang1, Zhan Hong Zheng1, Fei Gao1.   

Abstract

Hepatitis B virus X protein (HBx) is involved in the pathogenesis of hepatocellular carcinoma (HCC). Overexpression of the transcripts from the P3 and P4 promoters of the insulin-like growth factor-II (IGF-II) gene is observed in HCC. The present study investigated the involvement of HBx in IGF-II overexpression and its epigenetic regulation. Firstly, the effects of HBx on P3 and P4 mRNA expression, the methylation status of the P3 and P4 promoters, and MBD2 expression were analyzed in human HCC cells and HCC samples. Next, interaction between HBx and MBD2 or CBP/p300 was assessed by co-immunoprecipitation, and HBx-mediated binding of MBD2 and CBP/p300 to the P3 and P4 promoters and the acetylation of the corresponding histones H3 and H4 were evaluated by quantitative chromatin immunoprecipitation. Finally, using siRNA knockdown, we investigated the roles of MBD2 and CBP/p300 in IGF-II overexpression and its epigenetic regulation. Our results showed that HBx promotes IGF-II expression via inducing the hypomethylation of the P3 and P4 promoters, and that HBx increases MBD2 expression, directly interacts with MBD2 and CBP/p300, and elevates their recruitment to the hypomethylated P3 and P4 promoters with increased acetylation levels of the corresponding histones H3 and H4. Further results showed that endogenous MBD2 and CBP/p300 are necessary for HBx-induced IGF-II overexpression and that CBP/p300 presence and CBP/p300-mediated acetylation of histones H3 and H4 are partially required for MBD2 binding and its demethylase activity. These data suggest that HBx induces MBD2-HBx-CBP/p300 complex formation via interaction with MBD2 and CBP/p300, which contributes to the hypomethylation and transcriptional activation of the IGF-II-P3 and P4 promoters and that CBP/p300-mediated acetylation of histones H3 and H4 may be a rate-limiting step for the hypomethylation and activation of these two promoters. This study provides an alternative mechanism for understanding the pathogenesis of HBx-mediated HCC.

Entities:  

Keywords:  Hepatitis B virus X protein; MBD2-HBx-CBP/p300 complex; hepatocellular carcinoma; hypomethylation; insulin-like growth factor II

Year:  2015        PMID: 26045980      PMCID: PMC4449429     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  51 in total

1.  Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.

Authors:  Y Saito; Y Kanai; M Sakamoto; H Saito; H Ishii; S Hirohashi
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

Review 2.  Dysregulation of growth factor signaling in human hepatocellular carcinoma.

Authors:  K Breuhahn; T Longerich; P Schirmacher
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

Review 3.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

4.  A mammalian protein with specific demethylase activity for mCpG DNA.

Authors:  S K Bhattacharya; S Ramchandani; N Cervoni; M Szyf
Journal:  Nature       Date:  1999-02-18       Impact factor: 49.962

5.  Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.

Authors:  Julie Lucifora; Silke Arzberger; David Durantel; Laura Belloni; Michel Strubin; Massimo Levrero; Fabien Zoulim; Olivier Hantz; Ulrike Protzer
Journal:  J Hepatol       Date:  2011-03-02       Impact factor: 25.083

6.  Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.

Authors:  In Young Park; Bo Hwa Sohn; Eunsil Yu; Dong Jin Suh; Young-Hwa Chung; Je-Ho Lee; Stefan J Surzycki; Young Ik Lee
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

7.  Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.

Authors:  Nicholas Shukeir; Pouya Pakneshan; Gaoping Chen; Moshe Szyf; Shafaat A Rabbani
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

8.  Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection.

Authors:  Shao Hui Tang; Dong Hua Yang; Wei Huang; Min Zhou; Hong Ke Zhou; Xiao Hua Lu; Gang Ye
Journal:  Cancer Detect Prev       Date:  2006-05-12

Review 9.  Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.

Authors:  Kai Breuhahn; Peter Schirmacher
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

10.  Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.

Authors:  Per Lund; Dominic Schubert; Fataneh Niketeghad; Peter Schirmacher
Journal:  Cancer Lett       Date:  2004-03-31       Impact factor: 8.679

View more
  8 in total

Review 1.  Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

2.  Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms.

Authors:  Guifang Yu; Xuezhu Chen; Shudi Chen; Weipeng Ye; Kailian Hou; Min Liang
Journal:  Cancer Cell Int       Date:  2015-12-12       Impact factor: 5.722

3.  Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma.

Authors:  Dehai Wu; Hao Liang; Hao Wang; Changhu Duan; Hamza Yazdani; Jinan Zhou; Yujia Pan; Baga Shan; Zhilei Su; Jinping Wei; Tiangang Cui; Sheng Tai
Journal:  Oncol Lett       Date:  2018-07-19       Impact factor: 2.967

4.  HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis.

Authors:  Mei-Ling Dong; Xu Wen; Xin He; Ji-Hua Ren; Hai-Bo Yu; Yi-Ping Qin; Zhen Yang; Min-Li Yang; Chong-Yang Zhou; Hui Zhang; Sheng-Tao Cheng; Juan Chen
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 5.  Roles and regulation of histone acetylation in hepatocellular carcinoma.

Authors:  Jin-Kun Xia; Xue-Qian Qin; Lu Zhang; Shu-Jun Liu; Xiao-Lei Shi; Hao-Zhen Ren
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

Review 6.  Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma.

Authors:  Zelin Tian; Chen Xu; Peijun Yang; Zhibin Lin; Wenlong Wu; Wenjie Zhang; Jian Ding; Rui Ding; Xuan Zhang; Kefeng Dou
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

7.  MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.

Authors:  Wei Liu; Na Wang; Min Lu; Xiao-Juan Du; Bao-Cai Xing
Journal:  Mol Med Rep       Date:  2016-06-15       Impact factor: 2.952

Review 8.  Hepatitis B Virus X Protein and Hepatocarcinogenesis.

Authors:  Shuaichen Liu; Samantha S Y Koh; Caroline G L Lee
Journal:  Int J Mol Sci       Date:  2016-06-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.